Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Mark J. Abzug, Stephen Ira Pelton, Lin-Ye Song, Terence Fenton, Myron Levin, Sharon Appelbaum Nachman, William Borkowsky, Howard Max Rosenblatt, John F. Marcinak, Arry Dieudonne, Elaine J. Abrams, Indu Pathak. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.. Pediatric Infectious Disease Journal. 2006. 25: 920 - 929. PMID: 17006288

Year

2006

Journal

Pediatric Infectious Disease Journal

Study

P1024

Effects of HCV treatment on cytokine expression during HCV/HIV coinfection

Jason T. Blackard, Minhee Kang, Kenneth E. Sherman, Margaret James Koziel. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of Interferon and Cytokine Research. 2006. 26: 834-8.

Year

2006

Journal

Journal of Interferon and Cytokine Research

Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy

M. Atif Siddique, Kelly E. Hartman, Elvira Dragileva, Marla Silman, Tebeb Gebretsadik, Ayumi Shintani, Laurence Peiperl, Fred T. Valentine, Spyros A. Kalams. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. Journal of Infectious Diseases. 2006. 194: 661-5.

Year

2006

Journal

Journal of Infectious Diseases

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency

Marek J Nowicki, Sarah Palmer, Elias (Lou) K. Halvas, Ranier Ziermann, Grace M. Aldrovandi, Richard Y. Zhao, Peter Balfe, Cheryl L. Jennings, Ingrid A. Beck, James W. Bremer, Valerie F. Boltz, Donald J. Brambilla, John Coffin, John W. Mellors, Lisa M. Frenkel, J. Darren Hazelwood, Victoria A. Johnson, Mary Kearney, Andrea Kovacs, Daniel R. Kuritzkes, Karin J. Metzner, Dwight V. Nissley. Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. Journal of Clinical Microbiology. 2006. 44: 2612-4.

Year

2006

Journal

Journal of Clinical Microbiology

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

Ronald J. Bosch, Ronald T. Mitsuyasu, J. Michael Kilby, R. Pat Bucy, Donna Mildvan, Margaret A. Fischl, Jorge L. Santana, Jeffrey L. Lennox, Christopher D. Pilcher, Andrew R. Zolopa, Jody Lawrence, Richard B. Pollard, Rafaelle El-Habib, David Sahner, Lawrence Fox, Evgenia Aga. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).. Journal of Infectious Diseases. 2006. 194: 1672-6. PMID: 17109338

Year

2006

Journal

Journal of Infectious Diseases

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells

Tracey King, Lane R. Bushman, Jennifer J. Kiser, Peter Anderson, M. Graham Ray, Tom Delahunty, Courtney V. Fletcher. Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences. 2006. 843: 147-56.

Year

2006

Journal

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml

Yumi Mitsuya, Mark A. Winters, W. Jeffrey Fessel, Soo-Yon Rhee, Sally Slome, Michael Horberg, Leo Hurley, Jason Flamm, Daniel Klein, Robert Shafer. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml. Journal of Acquired Immune Deficiency Syndromes. 2006. 43: 56-59.

Year

2006

Journal

Journal of Acquired Immune Deficiency Syndromes

A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086

Constance A. Benson, Florin Vaida, Diane V. Havlir, Gerald F. Downey, Michael M. Lederman, Roy (Trip) Gulick, Marshall Jay Glesby, Michael Wantman, Christian J. Bixby, Alex R. Rinehart, Sally Snyder, Rui Wang, Sheran Patel, John W. Mellors. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. Journal of Infectious Diseases. 2006. 194: 1309-18.

Year

2006

Journal

Journal of Infectious Diseases

Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008

Adriana Weinberg, Philimon Gona, Sharon Appelbaum Nachman, Patricia Alexandra Defechereux, Ram Yogev, Walter T. Hughes, Diane W. Wara, Carol Elgie, Marlene A. Cooper, Wayne M. Dankner. Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008. Journal of Infectious Diseases. 2006. 193: 302-311.

Year

2006

Journal

Journal of Infectious Diseases

Study

P1008